Mick Assay

OTHER3 trials

Sponsors

Pierian Biosciences

Conditions

AdenocarcinomaBreast NeoplasmsCancerFallopian Tube NeoplasmsLung NeoplasmsOvarian NeoplasmsPeritoneal NeoplasmsSarcoma, Soft Tissue

Phase 2

Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis

CompletedNCT00243685

Pierian BiosciencesBreast Neoplasms, Lung Neoplasms, Ovarian Neoplasms +1

Start: 2006-09-30End: 2009-05-31Target: 150Updated: 2012-01-26

Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas

CompletedNCT00443196

Pierian BiosciencesAdenocarcinoma, Fallopian Tube Neoplasms, Ovarian Neoplasms +1

Start: 2006-03-31End: 2010-09-30Target: 150Updated: 2018-03-12

Unknown Phase

Demographics, Clinical Outcomes, and Physician Attitudes in Patients Who Have Received The MiCK Assay (CorrectChemo)

WithdrawnNCT02137811

Pierian BiosciencesCancer

Start: 2014-04-30End: 2016-06-30Updated: 2016-07-21